Gambro Dasco

Gambro Dasco is a leading medical technology entity specializing in the design and production of extracorporeal blood treatment systems, particularly for dialysis and intensive care. Based in Medolla, Italy, the company became a core part of Baxter International's Renal division following the acquisition of its parent company, Gambro, in 2013. Its portfolio includes hemodialysis monitors, filters, and specialized equipment for Continuous Renal Replacement Therapy (CRRT). The Medolla site serves as a critical center for research, development, and high-tech manufacturing for global renal markets. Gambro Dasco's innovations continue to support patients suffering from acute and chronic renal failure worldwide. The facility is recognized for its expertise in fluid management and blood purification technologies.